NCT07576426 Effects of Motor Control Retraining and Scapular Stabilization Exercises in Females With Scapular Dyskinesia.
| NCT ID | NCT07576426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Scapular Dyskinesis |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-10-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the combined effects of motor control retraining and scapular stabilization exercises on pain reduction, muscle strength improvement, and functional enhancement in breastfeeding females diagnosed with scapular dyskinesia, and to determine the effectiveness of this combined approach in addressing their musculoskeletal impairments.
Eligibility Criteria
Inclusion Criteria: * Currently breastfeeding (minimum 3 months postpartum) * Diagnosed with scapular dyskinesia (clinical tests such as the scapular dyskinesis test) * Complaints of shoulder or upper back pain during or after breastfeeding Exclusion Criteria: * History of shoulder surgery or recent trauma to the shoulder or spine * Neurological disorders affecting upper limb function (cervical radiculopathy). * Musculoskeletal conditions unrelated to scapular dyskinesia (rotator cuff tear, frozen shoulder) * Participation in any shoulder rehabilitation program in the past 3 months. * Contraindications to exercise (severe cardiopulmonary conditions or acute infections).
Contact & Investigator
hina gul, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576426 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Scapular Dyskinesis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576426 currently recruiting?
Yes, NCT07576426 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576426 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07576426 clinical trial?
NCT07576426 is sponsored by Riphah International University. The principal investigator is hina gul, PhD* at Riphah International University. The trial plans to enroll 34 participants.